Amar Murugan - 16 May 2024 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Signature
/s/ John Chao, Attorney-in-Fact for Amar Murugan
Issuer symbol
ATRA
Transactions as of
16 May 2024
Net transactions value
-$19,991
Form type
4
Filing time
20 May 2024, 20:33:56 UTC
Previous filing
06 Mar 2024
Next filing
20 Aug 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Sale $19,991 -32,401 -4.5% $0.6170 695,120 16 May 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
F2 The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2024 and May 17, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.